Literature DB >> 1777350

Metabolic reserve in normal myocardium assessed by positron emission tomography with C-11 palmitate.

N Tamaki1, M Kawamoto, N Takahashi, Y Yonekura, Y Magata, R Nohara, H Kambara, C Kawai, J Konishi.   

Abstract

Positron emission tomography (PET) with C-11 palmitate has been used in estimating the myocardial utilization of free fatty acid. To assess the metabolic reserve in normal subjects, a PET study was performed at control and during dobutamine infusion at 2 hour intervals in 5 normal subjects. Following monoexponential curve fitting of the time activity curve of the myocardium, the clearance half time (min) and residual fraction (%) were calculated as indices of beta-oxidation of free fatty acid. A significant increase in the heart rate and systolic blood pressure were observed during dobutamine infusion (65 +/- 5 vs 100 +/- 29 bpm, p less than 0.05 and 119 +/- 12 vs 144 +/- 16 mmHg, p less than 0.01, respectively). The clearance half time and the residual fraction were significantly decreased (23.4 +/- 2.6 vs 15.8 +/- 2.3 min and 67.0 +/- 2.5 vs 58.6 +/- 4.0%, P less than 0.05, each). When the left ventricular myocardium was divided into 4 segments, these indices were similar at control and uniformly decreased without regional differences during dobutamine infusion. These data suggest that beta-oxidation of free fatty acid may be uniformly increased in the left ventricular myocardium in relation to the increase in cardiac work in normal subjects. PET with C-11 palmitate at control and during dobutamine infusion is considered to be promising in assessing metabolic reserve in the myocardium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777350     DOI: 10.1007/bf03164614

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  21 in total

1.  Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.

Authors:  S L Meyer; G C Curry; M S Donsky; D B Twieg; R W Parkey; J T Willerson
Journal:  Am J Cardiol       Date:  1976-07       Impact factor: 2.778

2.  Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis.

Authors:  M Grover-McKay; H R Schelbert; M Schwaiger; H Sochor; P M Guzy; J Krivokapich; J S Child; M E Phelps
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

3.  C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs.

Authors:  H R Schelbert; E Henze; R Keen; H R Schon; H Hansen; C Selin; S C Huang; J R Barrio; M E Phelps
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

4.  C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium.

Authors:  H R Schön; H R Schelbert; G Robinson; A Najafi; S C Huang; H Hansen; J Barrio; D E Kuhl; M E Phelps
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

5.  Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.

Authors:  M Brown; D R Marshall; B E Sobel; S R Bergmann
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

6.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

7.  External detection and visualization of myocardial ischemia with 11C-substrates in vitro and in vivo.

Authors:  E S Weiss; E J Hoffman; M E Phelps; M J Welch; P D Henry; M M Ter-Pogossian; B E Sobel
Journal:  Circ Res       Date:  1976-07       Impact factor: 17.367

Review 8.  Evaluation of coronary artery disease in the patient unable to exercise: alternatives to exercise stress testing.

Authors:  H G Stratmann; H L Kennedy
Journal:  Am Heart J       Date:  1989-06       Impact factor: 4.749

9.  Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion.

Authors:  C Berthe; L A Pierard; M Hiernaux; G Trotteur; P Lempereur; J Carlier; H E Kulbertus
Journal:  Am J Cardiol       Date:  1986-12-01       Impact factor: 2.778

10.  Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease.

Authors:  J R Mason; R T Palac; M L Freeman; S Virupannavar; H S Loeb; E Kaplan; R M Gunnar
Journal:  Am Heart J       Date:  1984-03       Impact factor: 4.749

View more
  3 in total

1.  Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; S Nishizawa; N Sadato; E Tadamura; S Ono
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

Review 2.  Radionuclide techniques for the assessment of myocardial viability.

Authors:  E Skoufis; A I McGhie
Journal:  Tex Heart Inst J       Date:  1998

3.  Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; E Tadamura; K Okuda; S Ono; R Nohara
Journal:  Eur J Nucl Med       Date:  1993-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.